NIH-funded research R01 grant

New antibiotics from hidden microbes using digital discovery and sequencing

Official title: Bioinformatics guided synthesis of novel antibiotics from previously inaccessible microbial dark matter

Funded at Rockefeller University · NIH-11367630 · Data updated 2026-11-12

A scientist team at Rockefeller University is pursuing new antibiotics by reading DNA directly from environmental microbes to find hidden antibiotic genes and then turning those ideas into real drugs.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$798,670
NIH project number1R01AI193146-01A1
Project IDNIH-11367630 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients with difficult-to-treat bacterial infections or clinicians seeking new antibiotic options.

Less likely to help

Patients with infections caused by non-target pathogens or those without access to advanced healthcare settings may not directly benefit in the short term.

What this research studies

This project aims to unlock antibiotics by combining cutting-edge sequencing of environmental DNA with advanced bioinformatics to reveal new natural compounds that could fight drug-resistant bacteria. Researchers will bypass traditional culture methods, identify hidden biosynthetic gene clusters, and translate them into potential antibiotic candidates. The work blends genomics, computational biology, and chemistry to create a pipeline for discovering nature-inspired drugs that could help patients with resistant infections.

Why it matters

Potential benefit: If successful, the research could lead to new antibiotics that work against resistant bacteria, potentially improving treatment options for patients.

How similar studies have gone: Similar approaches have yielded novel antibiotic leads from genomic data, with several programs progressing to early experimental validation.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Brady, Sean F — Rockefeller University
  • Study coordinator: Brady, Sean F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.